Cargando…

Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer

Metastatic spread is the most important life-threatening feature of colorectal cancer and is supposed to be mainly driven by alterations in different carcinogenic pathways. The present study compared mutation and expression profiles of distinctive biomarkers in colorectal cancer patients with differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michl, M., Taverna, F., Kumbrink, J., Schiergens, T. S., Heinemann, V., Engel, J., Kirchner, T., Neumann, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990752/ https://www.ncbi.nlm.nih.gov/pubmed/33300106 http://dx.doi.org/10.1007/s00428-020-02983-6

Ejemplares similares

Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer
por: Jaitner, Stefanie, et al.
Publicado: (2022)

Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer
por: Boos, Sophie L., et al.
Publicado: (2021)

Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer
por: Heublein, Sabine, et al.
Publicado: (2018)

Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosis
por: Jacob, Sven, et al.
Publicado: (2021)

Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity
por: Woischke, Christine, et al.
Publicado: (2020)

Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL
por: Kumbrink, Jörg, et al.
Publicado: (2022)

Mechanisms of Metastasis in Colorectal Cancer and Metastatic Organotropism: Hematogenous versus Peritoneal Spread
por: Pretzsch, E., et al.
Publicado: (2019)

The association of immunosurveillance and distant metastases in colorectal cancer
por: Jacob, Sven, et al.
Publicado: (2021)

Colorectal Cancer with Uncommon Metastatic Spread
por: Dellavedova, Luca, et al.
Publicado: (2015)

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer
por: Ohnmacht, Alexander J., et al.
Publicado: (2023)

SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer
por: Neumann, Jens, et al.
Publicado: (2011)

Establishment of an Endoscopy-Guided Minimally Invasive Orthotopic Mouse Model of Colorectal Cancer
por: Chen, Chen, et al.
Publicado: (2020)

p130Cas Is Correlated with EREG Expression and a Prognostic Factor Depending on Colorectal Cancer Stage and Localization Reducing FOLFIRI Efficacy
por: Kumbrink, Jörg, et al.
Publicado: (2021)

Metastatic basal cell carcinoma with atypical pattern of spread
por: Gellatly, Matthew, et al.
Publicado: (2020)

Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting
por: Sultova, Elena, et al.
Publicado: (2021)

Distinct Genetic Alterations in Colorectal Cancer
por: Ashktorab, Hassan, et al.
Publicado: (2010)

Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer
por: Belardinilli, Francesca, et al.
Publicado: (2020)

Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance
por: Torlot, Lucien, et al.
Publicado: (2022)

Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial
por: von Einem, J. C., et al.
Publicado: (2014)

Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer
por: Palshof, Jesper Andreas, et al.
Publicado: (2017)

Genetic Alterations of Metastatic Colorectal Cancer
por: Testa, Ugo, et al.
Publicado: (2020)

NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU
por: Sultova, Elena, et al.
Publicado: (2020)

The DNA-polymorphism rs849142 is associated with skin toxicity induced by targeted anti-EGFR therapy using cetuximab
por: Froelich, Matthias F., et al.
Publicado: (2018)

Treatment patterns for metastatic colorectal cancer in Spain
por: Aranda, E., et al.
Publicado: (2020)

Metastatic Spread of Osteosarcoma
por: Price, C. H. G., et al.
Publicado: (1973)

Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites
por: Stewart, Colin J.R., et al.
Publicado: (2019)

Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa
por: Faria, Nuno R., et al.
Publicado: (2019)

A Rare Presentation of Colorectal Cancer with Unusual Progressive Intramuscular and Subcutaneous Metastatic Spread
por: Manafi-Farid, Reyhaneh, et al.
Publicado: (2019)

Human colorectal cancer-on-chip model to study the microenvironmental influence on early metastatic spread
por: Strelez, Carly, et al.
Publicado: (2021)

BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic options
por: Hummel, Michael, et al.
Publicado: (2021)

Distinct Urinary Metabolic Biomarkers of Human Colorectal Cancer
por: Zhu, Chang, et al.
Publicado: (2022)

Comprehensive characterization of distinct genetic alterations in metastatic breast cancer across various metastatic sites
por: Cha, Soojin, et al.
Publicado: (2021)

Metastatic Cancer of Apparent Colon Origin With No Intraluminal Cancer After Resection of Colorectal Lateral Spreading Lesions
por: Lee, Christopher J., et al.
Publicado: (2021)

Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials
por: Stahler, Arndt, et al.
Publicado: (2020)

Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms
por: Koenig, Alexander, et al.
Publicado: (2017)

Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer
por: Purcell, Rachel V., et al.
Publicado: (2017)

Non-Coding RNAs as Biomarkers of Tumor Progression and Metastatic Spread in Epithelial Ovarian Cancer
por: Seborova, Karolina, et al.
Publicado: (2021)

Pulmonary sclerosing hemangioma in a 21-year-old male with metastatic hereditary non-polyposis colorectal cancer: Report of a case
por: Schiergens, Tobias S, et al.
Publicado: (2011)

CD133 expression is an independent prognostic marker for low survival in colorectal cancer
por: Horst, D, et al.
Publicado: (2008)

Epigenetic inactivation of the extracellular matrix metallopeptidase ADAMTS19 gene and the metastatic spread in colorectal cancer
por: Alonso, Sergio, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2q0gpm1mhjjo7rgjjjnbp9ji2v